Explore more publications!

Press Releases

Water Soluble Films Market Size, Trends, Segments, Share and Companies 2025-35
MoneyHero Group partners with InsureMO to expand digital insurance access in the Philippines
ACA Pharma Announces Major Expansion of RYANODEX® Territory Outside the United States
Top Filipino professionals in Qatar and Kuwait honored at The Filipino Times Awards 2025
Sotavento Medios Expands in 2025: Launches AI-Driven 'Go Digital' Initiative in the Philippines and Australia
Philippines Hotels & Resorts Group Announces Black Friday x Travel Tuesday Sale with Discounts of Up to 56%
Canola Oil Market Size to Worth USD 47.84 Million by 2034, Driven by Health-Focused Consumption
Hap Chan, a Leading Chinese Restaurant Chain in the Philippines, Makes Repeat Order and Adopts Beyond Oil as the Standard in Their Frying Operation
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
7th Informal Consultations on the Philippines Singapore Action Plan (PSAP)

7th Informal Consultations on the Philippines Singapore Action Plan (PSAP)

LOCAL City Places Set for Launch January 1, 2026 for its Grocery Rebate Certificate Program in the Philippines
MEXC Foundation Sponsors Pre-Christmas Event for Children With Health Conditions in Philippines
De La Salle University Partners with Verified Market Research for Healthcare Fraud Analytics Market Study
Pharmaceutical Packaging Machines Regional Dynamics with Manufacturers and Suppliers Data
Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
AI-Powered, Human-Verified Marketplace Connecting U.S. Entrepreneurs with Trusted Filipino Virtual Assistants
Pharmaceutical Market to Reach USD 3,033.21 Billion by 2034 Driven by Rising Geriatric Population
ETP Group Analyzes How AI and Data Are Redefining Retail Promotions in the Philippines
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions